J&J Stock Dives As FDA Halts Covid Vaccine Use On Blood-Clotting Issue

The Food and Drug Administration halted use of Johnson & Johnson’s coronavirus vaccine on Tuesday on reports of blood clots in six recipients. In response, JNJ stock tripped.
Read More